Duchenne Muscular Dystrophy

Latest News


Latest Videos


Podcasts


CME Content


More News

Ifetroban may improve LVEF in patients with DMD. - REDPIXEL - stock.adobe.com

There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results suggest ifetroban may improve left ventricular ejection fraction in patients with DMD.

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo